Statins may decrease skeletal-related events in breast cancer patients with bone metastases

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1146-1147

  Dincer, Murat ^a   Bulut, Nilufer ^a   Harputluoglu, Hakan ^a   Altundag, Kadri ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; MEVALONIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; BONE PAIN; BREAST CANCER; CANCER PATIENT; DRUG EFFECT; HUMAN; HYPERCALCEMIA; NERVE ROOT COMPRESSION; OSTEOCLAST; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; SPINAL CORD COMPRESSION;

ACYL COENZYME A; APOPTOSIS; BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; CHOLESTEROL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEVALONIC ACID; NEOPLASM METASTASIS; OSTEOCLASTS;

EID: 33748181092     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.009     Document Type: Article

References (13)

1. Lipton A. Toward new horizons: the future of bisphosphonate therapy. Oncologist 9 Suppl. 4 (2004) 38-47
2. Coleman R.E. Management of bone metastases. Oncologist 5 (2000) 463-470
3. Jakobisiak M., and J G. Potential antitumor effects of statins (Review). Int J Oncol 23 (2003) 1055-1069
4. Jono S., and Nishizawa Y. Close relationship between bone and vasculature. Clin Calcium 12 (2002) 321-326
5. Komatsu Y., and Nakao K. Stimulation of bone formation by statins. Nippon Rinsho 62 Suppl. 2 (2004) 783-788
6. van Beek E., Pieterman E., Cohen L., Lowik C., and Papapoulos S. Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo. Biochem Biophys Res Commun 255 (1999) 491-494
7. van beek E., Lowik C., van der Pluijm G., and Papapoulos S. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a clue to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 14 (1999) 722-729
8. Istvan E.S., and J D. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 (2001) 1160-1164
9. Kort W.J., Hulsmann W.C., and Stehman T.E. Modulation of metastatic ability by inhibition of cholesterol synthesis. Clin Exp Metastasis 7 (1989) 517-523
10. Kaushal V., Kohli M., Mehta P., and Mehta J.L. Potential anticancer effects of statins: fact or fiction?. Endothelium 10 (2003) 49-58
11. Casey P.J., and Seabra M.C. Protein prenyltransferases. J Biol Chem 271 (1996) 5289-5292
12. Rejnmark L., Buus N.H., Vestergaard P., Andreasen F., Larsen M.L., and Mosekilde L. Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest 32 (2002) 581-589
13. Mundy G., Garrett R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949